16 analysts have shared their evaluations of Air Products & Chemicals APD during the recent three months, expressing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 6 | 6 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 1 | 3 | 2 | 0 | 0 |
| 2M Ago | 1 | 1 | 1 | 0 | 0 |
| 3M Ago | 2 | 2 | 2 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $297.75, along with a high estimate of $340.00 and a low estimate of $268.00. Observing a 8.35% increase, the current average has risen from the previous average price target of $274.81.
Analyzing Analyst Ratings: A Detailed Breakdown
In examining recent analyst actions, we gain insights into how financial experts perceive Air Products & Chemicals. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Joshua Spector | UBS | Raises | Neutral | $281.00 | $276.00 |
| Duffy Fischer | Barclays | Raises | Equal-Weight | $295.00 | $290.00 |
| Duffy Fischer | Goldman Sachs | Raises | Buy | $330.00 | $291.00 |
| John McNulty | BMO Capital | Raises | Outperform | $323.00 | $300.00 |
| Jeffrey Zekauskas | JP Morgan | Raises | Overweight | $340.00 | $300.00 |
| Michael Sison | Wells Fargo | Raises | Overweight | $280.00 | $240.00 |
| David Begleiter | Deutsche Bank | Lowers | Hold | $280.00 | $310.00 |
| Patrick Cunningham | Citigroup | Raises | Buy | $305.00 | $280.00 |
| John McNulty | BMO Capital | Raises | Outperform | $300.00 | $294.00 |
| Joshua Spector | UBS | Raises | Neutral | $268.00 | $257.00 |
| David Begleiter | Deutsche Bank | Raises | Buy | $310.00 | $260.00 |
| Steve Byrne | B of A Securities | Raises | Buy | $312.00 | $275.00 |
| Duffy Fischer | Barclays | Raises | Equal-Weight | $290.00 | $245.00 |
| John McNulty | BMO Capital | Raises | Outperform | $294.00 | $276.00 |
| Vincent Andrews | Morgan Stanley | Raises | Equal-Weight | $280.00 | $240.00 |
| John McNulty | BMO Capital | Raises | Outperform | $276.00 | $263.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Air Products & Chemicals. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Air Products & Chemicals compared to the broader market.
- Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Air Products & Chemicals's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Air Products & Chemicals's market position. Stay informed and make well-informed decisions with our Ratings Table.
Stay up to date on Air Products & Chemicals analyst ratings.
Unveiling the Story Behind Air Products & Chemicals
Since its founding in 1940, Air Products has become one of the leading industrial gas suppliers globally, with operations in 50 countries and 19,000 employees. The company is the largest supplier of hydrogen and helium in the world. It has a unique portfolio serving customers in a number of industries, including chemicals, energy, healthcare, metals, and electronics. Air Products generated $12.6 billion in revenue in fiscal 2023.
Financial Insights: Air Products & Chemicals
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Negative Revenue Trend: Examining Air Products & Chemicals's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -1.6% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Materials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 23.33%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Air Products & Chemicals's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.64% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.91%, the company showcases effective utilization of assets.
Debt Management: Air Products & Chemicals's debt-to-equity ratio surpasses industry norms, standing at 0.97. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
Analyst Ratings: What Are They?
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
